9 Meters Biopharma Inc.

NASDAQ: NMTR · Real-Time Price · USD
0.07
-0.06 (-44.71%)
At close: Jul 25, 2023, 10:00 PM

9 Meters Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
6.94M 12.65M 15.86M 29.46M 37.24M 46.99M 53.61M 64.02M 38.5M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
8.98K 7.28K 23.54M 5.58K 5.58K 5.58K 5.58K 5.58K 5.58K
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
1.57M 3.36M 2.59M 1.89M 1.85M 2.99M 2.01M 1.68M 1.41M
Total Current Assets
9.2M 33.02M 18.45M 31.35M 39.09M 49.99M 56.48M 65.78M 39.98M
Property-Plant & Equipment
106.75K 122.72K 139.45K 154.8K 170.96K 182.71K 195.59K 206.17K 218.36K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
115.73K 130K 23.68M 160.38K 176.53K 188.29K 201.17K 211.75K 223.94K
Total Assets
9.31M 33.15M 42.14M 31.51M 39.26M 50.17M 56.68M 65.99M 40.21M
Account Payables
4.23M 5.05M 1.44M 2.33M 1.91M 2.43M 1.32M 1.64M 1.37M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
5.13M 19.68M 2.71M 58.17K 56.46K 54.8K 53.19K 51.62K 50.1K
Other Current Liabilities
6.21M 5.96M 8.72M 6.96M 6.26M 5.97M 5.91M 5.03M 4.57M
Total Current Liabilities
15.58M 30.7M 12.86M 9.34M 8.22M 8.46M 7.28M 6.72M 5.99M
Long-Term Debt
34.77K 51.4K 15.81M 83.19K 98.39K 113.14K 127.46K 141.36K 154.85K
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
34.77K 51.4K 15.81M 83.19K 98.39K 113.14K 127.46K 141.36K 154.85K
Total Liabilities
15.61M 30.75M 28.67M 9.42M 8.32M 8.57M 7.41M 6.86M 6.14M
Total Debt
5.17M 19.73M 18.52M 141.36K 154.85K 167.94K 180.65K 192.98K 204.95K
Common Stock
1.43K 1.3K 1.3K 25.91K 25.82K 25.82K 25.55K 25.22K 21.63K
Retained Earnings
-226.48M -212.61M -200.68M -191.32M -180.19M -168.84M -159.29M -145.75M -137.49M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity
-6.3M 2.4M 13.46M 22.09M 30.94M 41.6M 49.27M 59.14M 34.07M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a